Showing results for Indiana Health

New psychiatry residency program hopes to ease physician shortage in northwest Indiana

Indiana University School of Medicine is partnering with the Northwest Indiana GME Consortium to launch a new psychiatry residency program at its regional campus in northwest Indiana aimed at treating an underserved population in that part of the state.

Christina Griffiths | Oct 20, 2020

IU researchers join nationwide effort to use artificial intelligence in study of Alzheimer's disease

A new $17.8 million grant will help researchers discover novel ways to prevent and treat Alzheimer’s disease through state-of-the-art artificial intelligence (AI) methods.

Christina Griffiths | Oct 15, 2020

Flora Hammond and Dawn Neumann examine data in their research center

Researchers developing model to help people with traumatic brain injury overcome long-term challenges

Researchers at Indiana University School of Medicine are hoping to develop a new model to help those who experience a traumatic brain injury (TBI) recover and better manage challenges that result from their injury.

Christina Griffiths | Oct 13, 2020

Walther bioinformatics grant Purdue IU Simon Cancer Center

Walther Cancer Foundation $11 million investment to expand IU-Purdue bioinformatics collaboration

The Walther Cancer Foundation will invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics — an increasingly critical aspect of their work.

IU School of Medicine | Oct 08, 2020

Kelvin Lee IU Simon Comprehensive Cancer Center

IU School of Medicine names new cancer center director, announces $15 million supporting gift from Walther Cancer Foundation

Indiana University School of Medicine has announced the hiring of a world-recognized medical oncologist and multiple myeloma researcher to lead the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, bolstered by a $15 million fund established by the Walther Cancer Foundation to support him in this role.

IU School of Medicine | Oct 07, 2020

IU researchers in nationwide network to study rare form of diabetes

Indiana University School of Medicine researchers are participating in the Rare and Atypical Diabetes Network (RADIANT), a nationwide study funded by the National Institutes of Health. The study seeks to discover new forms of diabetes, identify their causes, and understand how they differ from more common types of diabetes.

IU School of Medicine | Oct 06, 2020

Study: Negative pressure wound therapy device might not lower infection risk in women with obesity after C-section

Indiana University School of Medicine researchers are learning more about ways to prevent infections in women with obesity who have cesarean delivery.

Christina Griffiths | Sep 22, 2020

IU School of Medicine researchers receive multimillion-dollar grant to study potential new treatment for opioid addiction

Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.

Christina Griffiths | Sep 17, 2020

Steven Counsell Department of Medicine Dementia

IU School of Medicine, partners receive $1.3 million to deploy collaborative statewide dementia care model

Supported by a $1.3 million grant from the U.S. Administration for Community Living, Department of Health and Human Services, Indiana University School of Medicine and its partners have launched a 36-month venture to enhance, strengthen and expand supports for people with Alzheimer’s Disease and Related Dementias and their caregivers in 34 Indiana counties.

IU School of Medicine | Sep 14, 2020

IU Health University Hospital Indianapolis

IU School of Medicine selected for COVID-19 vaccine clinical trial

As researchers around the world work feverishly to discover a vaccine in the battle to prevent COVID-19, Indiana University School of Medicine has been selected as a site for a vaccine trial. Biopharmaceutical company AstraZeneca, in partnership with Oxford University, is moving forward with its late-stage clinical trial for a vaccine known as AZD1222.

IU School of Medicine | Sep 03, 2020